{
    "clinical_study": {
        "@rank": "90761", 
        "acronym": "ASAP", 
        "arm_group": {
            "arm_group_label": "18FAV45", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The primary objective of the study is to compare the brain amyloid load in fully, partially\n      and non remitting depressed elderly patients at 8 weeks of antidepressant therapy, by using\n      PET with [F18]AV45."
        }, 
        "brief_title": "Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amylo\u00efd Plaques (ASAP)", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Elderly", 
            "Major Depression"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Affective Symptoms", 
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major", 
                "Plaque, Amyloid"
            ]
        }, 
        "detailed_description": {
            "textblock": "The main aim of this study is to assess the brain amyloid load in treated depressed elderly\n      subjects using PET with [F18]AV45. The investigators hypothesize that the brain amyloid load\n      will be higher in non or partially remitting depressed subjects treated with antidepressants\n      than in fully remitting ones. An additional two years follow-up will allow comparing the\n      brain amyloid load at baseline between those who will have evolved towards MCI or MA and\n      those who will not, including ApoE genotype, the cognitive performances at baseline, the\n      hippocampus volume as assessed by MRI, the type and profile of mood disorder (number of past\n      episodes, age at first episode, vascular risk factor profile, response profile to\n      antidepressants), as covariates."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          -  Adult 60 years or older\n\n          -  Native language : french\n\n          -  Study period > 7 years\n\n          -  Major depression defined on the DSM-IV criteria assessed by MINI and HDRS score of 10\n             or over\n\n          -  Affiliation to the national health insurance system\n\n          -  Signed informed consent\n\n        Exclusion Criteria\n\n          -  History of alcoholism or drug addiction\n\n          -  MMSE less than or equal to 17\n\n          -  Major depression with psychotic features\n\n          -  Depressive episode resistant, patient who received two different antidepressants well\n             conducted without significant therapeutic response\n\n          -  Any current or past episode of mania, schizophrenia or any other psychotic disorder\n\n          -  Any past history of stroke or Parkinson's disease\n\n          -  Any current significant unstable illness\n\n          -  Any past diagnosis of Alzheimer's disease\n\n          -  Any current treatment by AcethylCholinesterae inhibitor, memantine or antidepressant\n             therapy.\n\n          -  Contraindications to MRI in patients with:\n\n               1. Metallic foreign body eye.\n\n               2. Any implanted electronic medical irremovably (pacemaker,    neurostimulator,\n                  cochlear implants ...)\n\n               3. Metal heart valve,\n\n               4. Vascular clips formerly located on cranial aneurysm.\n\n          -  Contraindications to antidepressants\n\n          -  History of progressive disease that can affect the central nervous system such as\n             uncontrolled diabetes, blood pressure greater than or equal to 180/100; chronic lung\n             disease with hypoxia, head trauma with loss of consciousness greater than or equal to\n             15 minutes; brain surgery, encephalitis, recently treated cancer (<1 year), altered\n             cerebral metabolism including subjects with stroke sequelae extended. Patients with\n             lacunar stroke without thalamic or striatal may be included."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01962753", 
            "org_study_id": "PHRN10-VC/ ASAP"
        }, 
        "intervention": {
            "arm_group_label": "18FAV45", 
            "description": "Admnistration of 18FAV45 if patient is compliant with one of those treatment: Seroplex, Zoloft, Deroxat, Venlafaxine, Mirtazapine, Moclamine,", 
            "intervention_name": "18FAV45", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Affective symptoms as prodromal stage of Alzheimer", 
        "lastchanged_date": "October 11, 2013", 
        "location": [
            {
                "contact": {
                    "email": "pierre.vandel@univ-fcomte.fr", 
                    "last_name": "Pierre VANDEL"
                }, 
                "facility": {
                    "address": {
                        "city": "Besan\u00e7on", 
                        "country": "France", 
                        "zip": "25030"
                    }, 
                    "name": "University Hospital of Besan\u00e7on- Jean Minjoz"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "dollfus-s@chu-caen.fr", 
                    "last_name": "Sonia DOLLFUS"
                }, 
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "zip": "14000"
                    }, 
                    "name": "University Hospital of Caen"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Jean.ROCHE@CHRU-LILLE.FR", 
                    "last_name": "Jean ROCHE"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59000"
                    }, 
                    "name": "University Hospital of Lille"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "robert.p@chu-nice.fr", 
                    "last_name": "Philippe ROBERT"
                }, 
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06000"
                    }, 
                    "name": "University Hospital of Nice"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "T.GALLARDA@ch-sainte-anne.fr", 
                    "last_name": "Thierry GALLARDA"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75014"
                    }, 
                    "name": "Sainte-Anne Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "marie.desbordes@ch-lerouvray.fr", 
                    "last_name": "Marie DESBORDES"
                }, 
                "facility": {
                    "address": {
                        "city": "Sotteville l\u00e8s Rouen", 
                        "country": "France", 
                        "zip": "76300"
                    }, 
                    "name": "Le Rouvray Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "frederic.blanc@chru-strasbourg.fr", 
                    "last_name": "Fr\u00e9d\u00e9ric BLANC"
                }, 
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67098"
                    }, 
                    "name": "University Hospital of Strasbourg - HUS"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "arbus.c@chu-toulouse.fr", 
                    "last_name": "Christophe ARBUS"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31059"
                    }, 
                    "name": "University Hospital of Toulouse - Purpan"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "vincent.camus@univ-tours.fr", 
                    "last_name": "Vincent CAMUS"
                }, 
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37000"
                    }, 
                    "name": "University Hospital of Tours"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amylo\u00efd Plaques (ASAP)", 
        "overall_contact": {
            "email": "vincent.camus@univ-tours.fr", 
            "last_name": "Vincent CAMUS", 
            "phone": "+33 247 47 91 30"
        }, 
        "overall_contact_backup": {
            "email": "valerie.gissot@univ-tours.fr", 
            "last_name": "Val\u00e9rie GISSOT", 
            "phone": "+33 234 37 96 53"
        }, 
        "overall_official": {
            "affiliation": "University Hospital of Tours", 
            "last_name": "Vincent CAMUS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament.", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "standards uptakes values (SUVr)", 
            "safety_issue": "No", 
            "time_frame": "2 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01962753"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The residual cognitive deficits (presence/absence) will be considered as a categorical variable.\nThe ApoE genotype will also be considered as categorical variables, as well as vascular risk factor profile, WMH at MRI. MADRS, NPI and IA scores as well as the hippocampus volume will be considered as continuous variables.", 
            "measure": "Residual cognitive deficits", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "University Hospital, Tours", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Tours", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}